Confirmed Worsening in the Symbol Digit Modalities Test and Timed 25-Foot Walk in Routine Multiple Sclerosis Care: A Retrospective Single-Center Longitudinal Study

Q4 Immunology and Microbiology
Kazuhiro Horiuchi, Shuntaro Nakamura, Kaede Ishikawa, Sumire Nunomura, Kazuki Yamada, Takashi Inoue, Kei Oiwa, Shintaro Fujii, Yuki Oshima, Akihiko Kudo, Ichiro Yabe
{"title":"Confirmed Worsening in the Symbol Digit Modalities Test and Timed 25-Foot Walk in Routine Multiple Sclerosis Care: A Retrospective Single-Center Longitudinal Study","authors":"Kazuhiro Horiuchi,&nbsp;Shuntaro Nakamura,&nbsp;Kaede Ishikawa,&nbsp;Sumire Nunomura,&nbsp;Kazuki Yamada,&nbsp;Takashi Inoue,&nbsp;Kei Oiwa,&nbsp;Shintaro Fujii,&nbsp;Yuki Oshima,&nbsp;Akihiko Kudo,&nbsp;Ichiro Yabe","doi":"10.1111/cen3.70065","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>Performance-based monitoring in multiple sclerosis (MS) is widely used, yet objective deterioration in routine regional practice is not well quantified. We aimed to estimate 24-month trajectories of cognitive processing speed and ambulation and to quantify confirmed worsening in these performance measures.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We performed a retrospective, single-center longitudinal study of 59 patients with repeated Symbol Digit Modalities Test (SDMT) and/or Timed 25-Foot Walk (T25FW) assessments. Linear mixed-effects models with random intercepts estimated marginal means at 0, 6, 12, 18, and 24 months, adjusting for prespecified covariates. T25FW was modeled on the log scale; unmeasurable T25FW was summarized separately. Confirmed performance worsening was defined as at least a 4-point SDMT decline or at least a 20% T25FW increase from baseline, confirmed at a reassessment at least 6 months later. Inference was restricted to 0–24 months.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Mean changes over 24 months were small, but observed paired changes varied widely. Confirmed performance worsening occurred in 7/59 patients (11.9%) for SDMT and 8/56 (14.3%) for T25FW (among those measurable at baseline). Unmeasurable T25FW was present in 3/59 (5.1%) at baseline and occurred during follow-up in 2/56 (3.6%) of baseline-measurable patients.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>In routine regional MS care, approximately one in eight patients met criteria for confirmed worsening in SDMT or T25FW during the 24-month observation period despite modest mean trends. Longitudinal monitoring should also capture transitions to unmeasurable walking status.</p>\n </section>\n </div>","PeriodicalId":10193,"journal":{"name":"Clinical and Experimental Neuroimmunology","volume":"17 3","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Neuroimmunology","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cen3.70065","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Immunology and Microbiology","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

Performance-based monitoring in multiple sclerosis (MS) is widely used, yet objective deterioration in routine regional practice is not well quantified. We aimed to estimate 24-month trajectories of cognitive processing speed and ambulation and to quantify confirmed worsening in these performance measures.

Methods

We performed a retrospective, single-center longitudinal study of 59 patients with repeated Symbol Digit Modalities Test (SDMT) and/or Timed 25-Foot Walk (T25FW) assessments. Linear mixed-effects models with random intercepts estimated marginal means at 0, 6, 12, 18, and 24 months, adjusting for prespecified covariates. T25FW was modeled on the log scale; unmeasurable T25FW was summarized separately. Confirmed performance worsening was defined as at least a 4-point SDMT decline or at least a 20% T25FW increase from baseline, confirmed at a reassessment at least 6 months later. Inference was restricted to 0–24 months.

Results

Mean changes over 24 months were small, but observed paired changes varied widely. Confirmed performance worsening occurred in 7/59 patients (11.9%) for SDMT and 8/56 (14.3%) for T25FW (among those measurable at baseline). Unmeasurable T25FW was present in 3/59 (5.1%) at baseline and occurred during follow-up in 2/56 (3.6%) of baseline-measurable patients.

Conclusion

In routine regional MS care, approximately one in eight patients met criteria for confirmed worsening in SDMT or T25FW during the 24-month observation period despite modest mean trends. Longitudinal monitoring should also capture transitions to unmeasurable walking status.

在多发性硬化症的常规护理中,符号数字模式测试和定时25英尺步行证实恶化:一项回顾性单中心纵向研究
目的基于绩效的多发性硬化症(MS)监测被广泛应用,但在常规的区域实践中,客观恶化并没有很好地量化。我们的目的是估计24个月的认知处理速度和移动轨迹,并量化这些性能测量的确认恶化。方法我们对59例患者进行了回顾性、单中心纵向研究,这些患者进行了重复符号数字模式测试(SDMT)和/或定时25英尺步行(T25FW)评估。随机截距的线性混合效应模型估计了0、6、12、18和24个月的边际均值,调整了预先指定的协变量。T25FW采用对数比例尺建模;不可测T25FW分别总结。确诊的表现恶化定义为SDMT下降至少4个点或T25FW比基线增加至少20%,至少6个月后重新评估确认。推断仅限于0-24个月。结果24个月的平均变化很小,但观察到的成对变化差异很大。在基线可测量的患者中,SDMT患者中有7/59(11.9%)和T25FW患者中有8/56(14.3%)证实表现恶化。3/59(5.1%)的患者在基线时出现无法测量的T25FW, 2/56(3.6%)的患者在随访期间出现T25FW。结论:在常规的区域MS护理中,尽管平均趋势不大,但在24个月的观察期内,大约有1 / 8的患者符合SDMT或T25FW确诊恶化的标准。纵向监测还应捕捉过渡到不可测量的行走状态。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical and Experimental Neuroimmunology
Clinical and Experimental Neuroimmunology Immunology and Microbiology-Immunology and Microbiology (miscellaneous)
CiteScore
1.60
自引率
0.00%
发文量
52
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书